Navigation Links
Stopping the worm from turning

Despite the clear arguments for controlling parasitic infections, we know surprisingly little about the developmental processes in parasitic nematodes. A good model system for research is provided by Oesophagostomum dentatum, a roundworm which infects the large intestines of pigs, slowing the animals' growth and leading to significant economic losses. A number of chemicals are available to help keep the parasite in check but the worms are growing increasingly resistant to their use and so there is a substantial need for new methods of treatment.

From eggs to parasites

The worm, Oesophagostomum dentatum, has a fairly simple life cycle. Eggs appear in the faeces around 3 weeks after ingestion of third-stage larvae, the so called L3 stage larvae. In the first two developmental stages, the larvae are not infective. The third-stage larvae migrate from the faeces into the surroundings, where they can again be ingested by pigs. When the parasite reaches the large intestine, the third-stage larvae burrow into the mucosal layer of the intestinal wall and moult to fourth-stage larvae. After a further 6-17 days they emerge from the mucosa and undergo a final moult before they mature into adults and reproduce.

Drug screen on worm proteins

Together with colleagues in Australia and the USA, Martina Ondrovics in the group of Anja Joachim at the University of Veterinary Medicine, Vienna (Vetmeduni) has undertaken a detailed in vitro investigation of the proteins involved in the transition from third-stage to fourth-stage larvae. The researchers employed an integrative approach that combined in vitro drug testing with proteomic and bioinformatic analysis. Previous work had identified a number of enzymes (hydrolases) that are likely to have a role in parasite development. Ondrovics used sophisticated techniques to examine the effects of certain compounds (enzyme inhibitors) on the larval protein composition.

Searching for functionality

Four of the seven enzyme inhibitors she tested were found to inhibit the development of L3 larvae. The inhibitors also caused substantial alterations in the amounts of certain proteins in the larvae. Ondrovics found that 22 proteins were expressed at significantly different levels. Although no functions could be assigned to three of the proteins, bioinformatics analysis suggested that the remainder are involved in a wide range of biological processes, including reproduction, cellular metabolic processes, multicellular organismal growth, developmental processes, growth, locomotion, response to stimuli, localization and biological regulation. It seems that the activities of these proteins are increased at the L3 to L4 transition, so the proteins are likely to have key functions at this time.

Designing new weapons against parasites

A better understanding of key developmental processes could enable new strategies to control parasitic nematodes based on the disruption of key biological pathways. The work at the Vetmeduni thus paves the way for future research to develop drugs that act specifically against parasitic nematodes. As Ondrovics says, "We urgently need new targets for intervention: the worms are rapidly becoming resistant to all the weapons at our disposal. The proteins we identified seem to be involved in fundamental developmental processes and we hope that functional studies will show that some of them are ideal candidate targets for the design of new and selective inhibitors."


Contact: Martina Ondrovics
University of Veterinary Medicine -- Vienna

Related biology news :

1. Einstein study reveals new approach for stopping herpes infections
2. Stopping smoking reduces risk of bacterial pneumonia in people with HIV
3. Stopping flies before they mature
4. Turning human stem cells into brain cells sheds light on neural development
5. Returning military personnel to duty following severe injury to the lower extremity
6. Researchers find molecular switch turning on self-renewal of liver damage
7. AZTI-Tecnalia is turning vegetable by-products destined for landfills into feedstuff
8. Zebrafish may hold the answer to repairing damaged retinas and returning eyesight to people
9. Why astronauts experience low blood pressure after returning to Earth from space
10. Turning ideas into products faster
11. Turning down the dial: Ocean energy development with less sound
Post Your Comments:
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
(Date:10/29/2015)... Oct. 29, 2015  Rubicon Genomics, Inc., today ... distribution of its DNA library preparation products, including ... new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been ... of NGS libraries for liquid biopsies--the analysis of ... prognostic applications in cancer and other conditions. Eurofins ...
(Date:10/27/2015)... , Oct. 27, 2015 In the present ... of concern for various industry verticals such as banking, ... to the growing demand for secure & simplified access ... ,sectors, such as hacking of bank accounts, misuse of ... equipment such as PC,s, laptops, and smartphones are expected ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... ... 2015 , ... Pittcon is pleased to announce the 2016 ... symposia, oral sessions, workshops, awards, and posters. The core of the Technical ... as, but not limited to, biotechnology, biomedical, drug discovery, environmental, food science, fuels/energy, ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; ... and prospects remain fundamentally strong and highlights the ... recently received DSMB recommendation to continue the ZoptEC ... of the final interim efficacy and safety data ... in men with heavily pretreated castration- and Taxane-resistant ...
(Date:11/24/2015)... LUMPUR, Malaysia , Nov. 24, 2015 /PRNewswire/ ... global contract research organisation (CRO) market. The trend ... result in lower margins but higher volume share ... increased capacity and scale, however, margins in the ... Research Organisation (CRO) Market ( ), ...
Breaking Biology Technology: